Display language
To modulepage Generate PDF

#70356 / #1

SS 2019 - SoSe 2023

English

Life Science Venturing

6

Kratzer, Jan

benotet

Schriftliche Prüfung

Zugehörigkeit


Fakultät VII

Institut für Technologie und Management

37335200 FG Entrepreneurship und Innovationsmanagement

Betriebswirtschaftslehre

Kontakt


H 76

Festel, Gunter

gunter.festel@festel.com

Learning Outcomes

The course will convey the important aspects of the founding and building up of a company using practice examples from the lifescience industry. Working in groups, students will acquire knowledge about the core elements of a business plan, financing, holding negotiations with investors including a due diligence and corporate valuation. The students should acquire the competence necessary to found and successfully build up their own company.

Content

This course provides an overview on the founding and building up of start-up companies with special This course focus on practise oriented aspects, such as financing and negotiation strategies. 1. Importance of start-up companies 2. Founding and building up of start-ups 2.1. Drawing up a business concept and business plan 2.2. Preparation and establishing a company 3. Operative building up of a company 4. Financing of companies 4.1. Co-operation with business angels 4.1. Co-operation with venture capital 5. Company assessment/valuation 6. Development and execution of an exit strategy

Module Components

Pflichtgruppe:

All Courses are mandatory.

Course NameTypeNumberCycleLanguageSWSVZ
Life Science EntrepreneurshipIVSoSeEnglish4

Workload and Credit Points

Life Science Entrepreneurship (IV):

Workload descriptionMultiplierHoursTotal
Class attendance15.04.0h60.0h
Class preparation and follow-up15.08.0h120.0h
180.0h(~6 LP)
The Workload of the module sums up to 180.0 Hours. Therefore the module contains 6 Credits.

Description of Teaching and Learning Methods

Lifescience Venturing is a guideline for those concerned with the creation, management and support of early stage companies in the medical technology, molecular biology, biochemistry, biophysics, bioinformatics or immunology sectors. Through a clear thematic structure, practise related recommendations and real case studies, participants will obtain a fast and comprehensive insight into this specific topic. The course as integrative course is a mix of lectures, interactive teaching, group work and individual work.

Requirements for participation and examination

Desirable prerequisites for participation in the courses:

Students in the area of life sciences, who wish to specifically concern themselves with the aspect of business creation / prospective founders in the area of life sciences

Mandatory requirements for the module test application:

This module has no requirements.

Module completion

Grading

graded

Type of exam

Written exam

Language

English

Duration/Extent

2 Stunden

Duration of the Module

The following number of semesters is estimated for taking and completing the module:
1 Semester.

This module may be commenced in the following semesters:
Sommersemester.

Maximum Number of Participants

The maximum capacity of students is 40.

Registration Procedures

For course registration please send an email to Charleen von Kolpinski (vonkolpinski@campus.tu- berlin.de) indicating your name, email address and student number. The application starts in the first week of lecturing. Emails before that time won’t be considered.

Recommended reading, Lecture notes

Lecture notes

Availability:  unavailable

 

Electronical lecture notes

Availability:  unavailable

 

Literature

Recommended literature
Achleitner A.-K., Nathusius E. (2004): Venture Valuation – Bewertung von Wachstumsunternehmen, 1. edition, Stuttgart
Ermisch R., Thoma P. (2002): Zehn Schritte zum Venture-Capital - Ein Ratgeber für junge Technologieunternehmen, DPunkt Verlag, Heidelberg
Erikson T., Sørheim R. (2005): Technology angels and other informal investors, Technovation, Vol. 25, p. 489-496
Fath C. (2004): Konfigurationstheoretische Analyse der Business-Angel-Finanzierung in Österreich, Dissertation, Wirtschaftsuniversität Wien
Holaday J.W., Meltzer S.L., McCormick J.T. (2003): Strategies for attracting angel investors, Journal of Commercial Biotechnology, Vol. 9, No. 2, p. 129-133
Leopold G., Fromman H. (1998): Eigenkapital für den Mittelstand, München
Madill J., Haines G., Riding A. (2005): The Role of Angels in Technology SMEs - A Link to Venture Capital, Venture Capital - An International Journal of Entrepreneurial Finance, Vol. 7, No. 2, p. 107- 129
Mason C. (2006): Informal Sources of Venture Finance, in: Parker S. (Hrsg.), The Life Cycle of Entrepreneurial Ventures, International Handbook on Entrepreneurship, Vol. 7, Springer, New York, p. 259-299
Mason C.M., Harrison R.T. (2002): Is it worth it? - The rates of return from informal venture capital investments, Journal of Business Venturing, Vol. 17, p. 211-236
Maunula M. (2006): The Perceived Value-Added of Venture Capital Investors - Evidence from Finnish Biotechnology Industry, Discussion Paper 1030, ETLA Research Project The Development of Biotechnology Industry in Finland, The Research Institute of the Finnish Economy, Helsinki
Meyer T. (2006): Venture Capital in Europa – Mehr Pep für Europas Wirtschaft, Deutsche Bank Research, Frankfurt
Rind K.W. (1981): The role of venture capital in corporate development, Strategic Management Journal, Vol. 2, No. 2, p. 169-180
Schefczyk M. (2000): Finanzieren mit Venture Capital, Stuttgart

Assigned Degree Programs


This module is used in the following Degree Programs (new System):

Studiengang / StuPOStuPOsVerwendungenErste VerwendungLetzte Verwendung
This module is not used in any degree program.

Miscellaneous

No information